SecBot SecBot
SECBOTREPLAY Home › Report › SRPT

SRPT · Sarepta Therapeutics filed a definitive proxy statement (DEFA14A) for…

Sarepta Therapeutics, Inc. · DEFA14A filed Apr 24, 2026 at 16:11 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 24, 2026 at 16:11 ET

Sarepta Therapeutics filed a definitive proxy statement (DEFA14A) for its annual shareholder meeting, which includes routine information about director elections, executive compensation, and other corporate governance matters. The filing is standard and does not contain any material changes or unexpected events.

  • Filing is a routine DEFA14A proxy statement for Sarepta Therapeutics
  • Contains standard information about director elections, executive compensation, and corporate governance
  • No material changes, unexpected events, or activist campaign mentioned
  • Filing is required for annual shareholder meeting

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access